Thomas I.H. Dubin's most recent trade in Intensity Therapeutics Inc was a trade of 50,000 Stock Option (right to buy Common Stock) done . Disclosure was reported to the exchange on May 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intensity Therapeutics Inc | Thomas I.H. Dubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | Thomas I.H. Dubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy Common Stock) | |
| Notable Labs Inc | Thomas I.H. Dubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 40,247 | 40,247 | - | 0 | Ordinary Shares | |
| Notable Labs Inc | Thomas I.H. Dubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 9,753 | 9,753 | - | - | Stock Option |